Ado-trastuzumab emtansine Intravenous and Insulin Glargine (U-300) Pens
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Insulin glargine and lixisenatide
- Ado-trastuzumab emtansine Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Insulin glargine, recombinant Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Insulin glulisine
- Ado-trastuzumab emtansine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Ado-trastuzumab emtansine Intravenous-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Adox Pak 2/100
- Insulin Glargine (U-300) Pens-Adoxa
- Insulin Glargine (U-300) Pens-Adoxa CK
- Insulin Glargine (U-300) Pens-Adoxa Pak
- Insulin Glargine (U-300) Pens-Adoxa Pak 1/100
- Insulin Glargine (U-300) Pens-Adoxa Pak 1/150